we infused the selective dopamine1 receptor agonist , fenoldopam mesylate ( skf 82526 j ) , to evaluate hemodynamic and neurohumoral changes during continuous intravenous infusion in patients with congestive heart failure and compared them with the effects of nitroprusside , a traditional vasodilator that works by a distinctly different mechanism .
C0700481
fenoldopam mesylate
C0018802
congestive heart failure